US 10619157
Cancer treatment
granted A61KA61K31/7115A61K31/712
Quick answer
US patent 10619157 (Cancer treatment) held by Ionis Pharmaceuticals, Inc. expires Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Ionis Pharmaceuticals, Inc.
- Grant date
- Tue Apr 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 32
- CPC classes
- A61K, A61K31/7115, A61K31/712, A61K31/7125, A61P